BC
RPTP

Broadfin Capital’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Broadfin Capital’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-664,800
Closed -$5.96M – 78
2016
Q3 		$5.96M Sell
664,800
-5,785,200
-90% -$41.1M 0.53% 48
2016
Q2 		$34.6M Sell
6,450,000
-550,000
-8% -$2.82M 3.37% 8
2016
Q1 		$32.2M Buy
7,000,000
+4,587,005
+190% +$18.4M 3.11% 8
2015
Q4 		$12.5M Buy
2,412,995
+1,000,000
+71% +$5.8M 0.77% 33
2015
Q3 		$8.55M Buy
1,412,995
+93,112
+7% +$1.14M 0.48% 54
2015
Q2 		$20.8M Buy
+1,319,883
New +$16M 1.12% 21
2015
Q1 		– Sell
-15,558
Closed -$164K – 98
2014
Q4 		$164K Buy
+15,558
New +$152K 0.01% 75

Broadfin Capital's RPTP Position: Q4 2016 in Review

Broadfin Capital sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 664,800 shares — an estimated $5.96M sold.

Broadfin Capital first reported a position in RPTP in Q4 2014 and held it in 7 quarters. The position peaked at $34.6M in Q2 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Broadfin Capital reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Broadfin Capital sold 664,800 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $5.96M.
  • Broadfin Capital first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q4 2014 and held it in 7 quarters.
  • Broadfin Capital's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $34.6M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Broadfin Capital's 13F filing for Q4 2016, filed 14 Feb 2017.